Association Between Serum Levels of Zinc, Copper, and Magnesium and Chemotherapy Response in Patients with Gastric Cancer
International Journal of Cancer Management · 03.10.2026 · 19 (1)
DOI: 10.5812/ijcm-168748 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer Management, online erschienen am 03.10.2026. Verfasst von Yousef Roosta und 2 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Gastric cancer remains a leading cause of cancer-related mortality worldwide and demonstrates heterogeneous responses to standard platinum-based chemotherapy.
Objectives
This study aimed to assess the predictive value of baseline serum zinc, copper, and magnesium levels for the clinical response to first-line chemotherapy in patients with gastric cancer.
Methods
This pilot descriptive-analytical study was conducted at the Department of Oncology, Imam Khomeini Hospital, affiliated with Urmia University of Medical Sciences, Urmia, Iran, from August 2024 to September 2025. The study enrolled 27 patients with histologically confirmed gastric cancer receiving standard chemotherapy. Pretreatment serum zinc, copper, and magnesium concentrations were measured using colorimetric assays. Treatment response was assessed after two cycles according to the Response Evaluation Criteria in Solid Tumors, version 1.1. Associations between trace-element levels and chemotherapy response, defined as complete response (CR) versus non-complete response (non-CR), were analyzed using independent t-tests and multivariate logistic regression. The non-CR group included 2 patients with partial response and 10 with stable/progressive disease or no response.
Results
The cohort was predominantly male (74.1%) and had a mean age of 61.89 ± 9.53 years. Patients achieving CR had significantly higher baseline serum zinc levels (100.26 ± 38.14 µg/dL) than those with non-CR (73.25 ± 22.41 µg/dL; P = 0.040). Mean serum magnesium levels were higher in patients with CR than in those with non-CR (2.12 vs. 2.00 mg/dL), although the difference was not statistically significant (P = 0.168). Serum copper levels did not differ significantly between groups (P = 0.950). Logistic regression showed a borderline trend toward lower odds of non-CR with higher serum zinc levels (P = 0.056).
Conclusions
Baseline serum zinc levels showed a statistically significant univariate association with early radiologic response to first-line chemotherapy in patients with gastric cancer. However, given the pilot sample size and the borderline multivariate trend (P = 0.056), this observational finding should be considered exploratory rather than definitive evidence of predictive utility. Therefore, claims regarding routine clinical implementation are premature. These results provide hypothesis-generating evidence, preliminary effect size estimates, and design parameters for future prospective, adequately powered biomarker validation trials.
Zitieren
APA
Roosta, Y., Kaboudmehri, M., & Azar, M. R. H. (2026). Association Between Serum Levels of Zinc, Copper, and Magnesium and Chemotherapy Response in Patients with Gastric Cancer. International Journal of Cancer Management, 19(1). https://doi.org/10.5812/ijcm-168748
Vancouver
Roosta Y, Kaboudmehri M, Azar MRH. Association Between Serum Levels of Zinc, Copper, and Magnesium and Chemotherapy Response in Patients with Gastric Cancer. International Journal of Cancer Management. 2026;19(1). doi:10.5812/ijcm-168748
BibTeX
@article{Roosta2026,
author = {Roosta, Yousef and Kaboudmehri, Mahsa and Azar, Mohammad Reza Hosseini},
title = {Association Between Serum Levels of Zinc, Copper, and Magnesium and Chemotherapy Response in Patients with Gastric Cancer},
journal = {International Journal of Cancer Management},
year = {2026},
volume = {19},
number = {1},
doi = {10.5812/ijcm-168748}
}
EUVIMED